Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Danimer Scientific's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $278.02 Mil. Danimer Scientific's Total Assets for the quarter that ended in Dec. 2023 was $698.13 Mil.
Therefore, Danimer Scientific's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.40.
The historical rank and industry rank for Danimer Scientific's Equity-to-Asset or its related term are showing as below:
DNMR'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.12 Med: 0.53 Max: 0.65
Current: 0.4
During the past 5 years, the highest Equity to Asset Ratio of Danimer Scientific was 0.65. The lowest was 0.12. And the median was 0.53.
DNMR's Equity-to-Asset is ranked worse than 78.94% of 1572
companies
in the Chemicals industry
Industry Median: 0.59
vs DNMR: 0.40
Danimer Scientific Equity-to-Asset Historical Data
The historical data trend for Danimer Scientific's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Danimer Scientific's Equity-to-Asset
For the Specialty Chemicals subindustry, Danimer Scientific's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Danimer Scientific's Equity-to-Asset Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Danimer Scientific's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Danimer Scientific's Equity-to-Asset falls into.
Danimer Scientific Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Danimer Scientific's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Danimer Scientific Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Danimer Scientific's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Danimer Scientific (Danimer Scientific) Business Description
Danimer Scientific Inc creates more sustainable, more natural ways to make plastic products sold under the proprietary Nodax brand name. The company's renewable and sustainable biopolymers have helped create plastic products that are 100% biodegradable and compostable. Danimer Scientific's products return to nature instead of polluting lands and waters. Its technology can be found in a vast array of plastic end-use products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles, among others. The company holds more than 470 patents and pending patent applications in nearly 20 countries for a range of manufacturing processes and biopolymer formulations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DNMR has been successfully added to your 